These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9012206)

  • 1. [Amyotrophic lateral sclerosis].
    Wien Med Wochenschr; 1996; 146(9-10):181-220. PubMed ID: 9012206
    [No Abstract]   [Full Text] [Related]  

  • 2. A molecular genetic approach to amyotrophic lateral sclerosis.
    Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
    Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Dobosz B
    Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function.
    Lulé D; Diekmann V; Kassubek J; Kurt A; Birbaumer N; Ludolph AC; Kraft E
    Neurorehabil Neural Repair; 2007; 21(6):518-26. PubMed ID: 17476000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontal lobe dysfunction in ALS].
    Alcaz S; Apostolski S
    Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the copper-zinc superoxide dismutase gene in amyotrophic lateral sclerosis.
    Nishiyama K; Murayama S; Kwak S; Kanazawa I
    Ann Neurol; 1997 Apr; 41(4):551-6. PubMed ID: 9124814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution to the familial occurrence of amyotrophic lateral sclerosis. Studies on amyotrophic lateral sclerosis. VI].
    SERCL M; KOVARIK J
    Cesk Neurol; 1960 Oct; 23():406-11. PubMed ID: 13750173
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development of levetiracetam for amyotrophic lateral sclerosis.
    Davies SL; Moral MA
    Drug News Perspect; 2006 Nov; 19(9):572-3. PubMed ID: 17220961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis.
    Rowland LP
    Ann Neurol; 1997 Jun; 41(6):703-5. PubMed ID: 9189030
    [No Abstract]   [Full Text] [Related]  

  • 10. Is prostaglandin E(2) a pathogenic factor in amyotrophic lateral sclerosis?
    Almer G; Kikuchi H; Teismann P; Przedborski S
    Ann Neurol; 2006 Jun; 59(6):980-3. PubMed ID: 16619237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database.
    Miller RG; Anderson F; Brooks BR; Mitsumoto H; Bradley WG; Ringel SP;
    Ann Neurol; 2009 Jan; 65 Suppl 1():S24-8. PubMed ID: 19191307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory treatment of amyotrophic lateral sclerosis.
    Benditt JO; Boitano L
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):559-72, x. PubMed ID: 18625416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patulous eustachian tube complicated with amyotrophic lateral sclerosis: a video clip demonstration.
    Takasaki K; Kumagami H; Umeki H; Enatsu K; Takahashi H
    Laryngoscope; 2008 Nov; 118(11):2057-8. PubMed ID: 18695625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What are management practices for speech therapy in amyotrophic lateral sclerosis?].
    Sancho PO; Boisson D
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S273-4S274. PubMed ID: 17128124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyotrophic lateral sclerosis that begins with voice and deglution alterations].
    Faubel Serra M; Pardo Mateu L; Perez Climent F; Llavero Segovia MT; Cano Cuenca B; Grau Alario E; Gimenez Vaillo F; Canals Ruiz P
    An Otorrinolaringol Ibero Am; 2006; 33(3):273-80. PubMed ID: 16881554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What's new in primary lateral sclerosis?].
    Le Forestier N; Maisonobe T; Spelle L; Lesort A; Salachas F; Chassande B; Bouche P; Samson Y; Meininger V
    Rev Neurol (Paris); 2000 Apr; 156(4):364-71. PubMed ID: 10795013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI in amyotrophic lateral sclerosis: hyperintensity of the corticospinal tract.
    Kriaa S; Zbidi M; Hafsa C; Golli M; Gannouni A
    Neurol Clin Neurophysiol; 2005 Dec; 2005():3. PubMed ID: 17139392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical differentiation between primary lateral sclerosis and upper motor neuron predominant amyotrophic lateral sclerosis.
    Gotkine M; Argov Z
    Arch Neurol; 2007 Oct; 64(10):1545; author reply 1545. PubMed ID: 17923644
    [No Abstract]   [Full Text] [Related]  

  • 20. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
    Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.